SCHEMBL14497312

SCHEMBL14497312

CC(C)C1CC12CCN(C(C)C)C2

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 4/20 0.33
▸ CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24819398 1.00 HRH3 (0.33) HRH3CYP2D6
SCHEMBL19008943 0.88 HRH3 (0.38) HRH3CYP2D6
SCHEMBL22209271 0.83 — —
SCHEMBL14524118 0.82 HRH3 (0.33) HRH3CYP2D6
SCHEMBL16984291 0.79 HRH3 (0.35) HRH3CYP2D6
SCHEMBL19756456 0.78 CYP2D6 (0.36) HRH3CYP2D6
SCHEMBL19756448 0.78 CYP2D6 (0.36) HRH3CYP2D6
SCHEMBL19251316 0.78 CYP2D6 (0.36) HRH3CYP2D6
SCHEMBL19756436 0.78 CYP2D6 (0.36) HRH3CYP2D6
SCHEMBL19756451 0.78 CYP2D6 (0.36) HRH3CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023283263-A1 CITRATE SALT, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME FOGHORN THERAPEUTICS INC. (US) 2023-01-12 — — WO disclosed
US-7229996-B2 Rifamycin derivatives CUMBRE PHARMACEUTICALS INC. (US) 2007-06-12 — — US disclosed
US-7202246-B2 Spiro-rifamycin derivatives targeting RNA polymerase CUMBRE PHARMACEUTICALS INC. (US) 2007-04-10 — — US disclosed
Send feedback